Ascelia Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Millions SEK. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	33.89	49.86	75.26	21.86	149.56	261.6
Cash & Short-Term Investments	33.89	49.86	75.26	21.86	149.56	261.6
Cash Growth	-40.86%	-33.75%	244.34%	-85.39%	-42.83%	41.64%
Other Receivables	3.76	2.77	5.69	2.46	4.53	5.56
Total Trade Receivables	3.76	2.77	5.69	2.46	4.53	5.56
Other Current Assets	1.47	1.3	2.78	4.62	6.79	7.45
Total Current Assets	39.12	53.94	83.72	28.94	160.87	274.61
Net Property, Plant & Equipment	0.68	0.94	0.12	1.06	0.63	1.82
Other Intangible Assets	57.07	57.07	57.08	57.07	57.07	57.06
Total Assets	96.87	111.94	140.92	87.07	218.57	333.49
Accounts Payable	3.49	2.04	4.73	1.53	15.88	6.15
Accrued Expenses	8.73	8.48	12.73	8.52	19.66	16.34
Current Portion of Long-Term Debt	-	-	25.23	-	-	-
Current Portion of Leases	0.69	0.9	0.17	0.88	0.29	1.1
Other Current Liabilities	1.04	0.97	19.11	1.64	1.69	1.51
Total Current Liabilities	13.95	12.4	61.98	12.57	37.52	25.11
Long-Term Leases	-	0.07	-	0.18	0.19	0.55
Total Long-Term Liabilities	-	0.07	-	0.18	0.19	0.55
Total Liabilities	13.95	12.47	61.98	12.74	37.71	25.66
Common Stock	127.9	127.9	97.19	34.87	34.87	34.58
Additional Paid-in Capital	771.37	771.37	721.75	678.75	678.75	678.83
Accumulated Other Comprehensive Income	1.02	1.11	0.97	0.67	0.97	0.25
Retained Earnings	-817.36	-800.9	-740.97	-639.96	-533.73	-405.83
Shareholders' Equity	82.92	99.47	78.94	74.33	180.86	307.83
Total Liabilities & Equity	96.87	111.94	140.92	87.07	218.57	333.49
Total Debt	0.69	0.97	25.4	1.06	0.48	1.66
Net Cash (Debt)	33.2	48.89	49.86	20.8	149.07	259.94
Net Cash Growth	-32.10%	-1.94%	139.76%	-86.05%	-42.65%	42.12%
Net Cash Per Share	0.27	0.43	0.92	0.62	4.28	7.89
Book Value	82.92	99.47	78.94	74.33	180.86	307.83
Book Value Per Share	0.69	0.88	1.46	2.20	5.20	9.34
Tangible Book Value	25.85	42.4	21.87	17.25	123.79	250.77
Tangible Book Value Per Share	0.21	0.37	0.40	0.51	3.56	7.61